On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are LUMOBIOTICS GmbH's own share of each project, not the project's full budget.
- Horizon Europe€180k · 1 project
- Horizon 2020€166k · 1 project
Projects
2 EU-funded projects, newest first. Each links to the official record.
- LIGHTHERPartner
First-in-kind anticancer therapy combining light-controllable cytotoxic peptides and dendritic cell-based immunotherapy
Horizon Europe · 2026–2029 · Project on CORDIS ↗
€180ktheir share - ALISEPartner
Anti-Cancer Light-Controllable Antibody-Peptide Conjugates
Horizon 2020 · 2021–2026 · Project on CORDIS ↗
€166ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Karlsruher Institut Fuer TechnologieGermany · 2 shared projects
- Stichting Amsterdam UmcNetherlands · 2 shared projects
- National Cancer Institute State Non-Profit EnterpriseUkraine · 2 shared projects
- The Chancellor Masters and Scholars of the University of CambridgeUnited Kingdom · 1 shared project
- "Valsts zinatniskais instituts ""Nacionalais petniecibas un inovaciju instituts"""Latvia · 1 shared project
- Taras Shevchenko National University of KyivUkraine · 1 shared project
- Enamine Limited Liability Company,research and Production EnterpriseUkraine · 1 shared project
- Bienta Limited CompanyUkraine · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- biomolecules
- cell biology
- drug discovery
- immunology
- immunotherapy
- lung cancer
- oncology
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.